SUBSCRIBE
SUBSCRIBE

Australia

Drug Development
Vaccine To Slow Cancer Growth Closer To Human Trials, University of Sydney Reveals
June 28, 2017
 · 
1 min read
5 Biotechs Awaiting Big News From the FDA in July
Drug Development
GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock
June 28, 2017
 · 
3 min read
Business
Sirtex Medical Cuts 15% of Workforce in Restructuring
June 28, 2017
 · 
1 min read
11 Life Science Skills You'll Need in 2020
Biotech Bay
11 Life Science Skills You’ll Need in 2020
June 26, 2017
 · 
7 min read
The Most Common Mistake Scientists Make When Applying for a Job
Biotech Beach
Most Common Mistake Scientists Make When Applying for a Job
June 26, 2017
 · 
5 min read
What Does It Take to Get Hired by GlaxoSmithKline and AbbVie
Biotech Bay
What Does It Take to Get Hired by GlaxoSmithKline and AbbVie
June 23, 2017
 · 
5 min read
Genetown
11 Signs You Aced Your Interview
June 20, 2017
 · 
1 min read
Genetown
6 Must-Ask Questions Before Accepting The Job Offer
June 20, 2017
 · 
1 min read
Genetown
10 Resume Rules Smart Job Seekers Break
June 20, 2017
 · 
1 min read
Genetown
Avoid Doing These 3 Things At Your Biotech Or Biopharma Jobs Interview
June 20, 2017
 · 
1 min read
Load More
PRESS RELEASES
Opthea to Present at the FLORetina 2023 Congress
December 1, 2023
 · 
2 min read
Drug Development
Registrational Phase III CLARIFY trial in prostate cancer commences
November 30, 2023
 · 
5 min read
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
November 30, 2023
 · 
8 min read
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
November 29, 2023
 · 
6 min read
Drug Development
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
November 29, 2023
 · 
7 min read
Biotech Beach
US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study
November 29, 2023
 · 
4 min read
Drug Development
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes
November 29, 2023
 · 
7 min read
Kazia Announces Non-binding Letter of Intent for the Proposed Granting of Rights to Develop and Commercialize Paxalisib Outside of Oncology
November 29, 2023
 · 
4 min read
Recce Pharmaceuticals Granted New Patent in Canada for RECCE® Anti-Infectives
November 27, 2023
 · 
4 min read
Biotech Bay
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
November 27, 2023
 · 
7 min read
Pharm Country
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
November 26, 2023
 · 
3 min read
Drug Development
Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa
November 26, 2023
 · 
6 min read
Drug Development
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
November 22, 2023
 · 
3 min read
Kazia Provides Overview of Paxalisib Related Presentations From the Society of Neuro-Oncology 2023 Annual Meeting
November 21, 2023
 · 
7 min read
Drug Development
Sapient Therapeutics Announce Positive Results From Phase 1 Part A Trial for Its Solid Dose Prescription CBD
November 21, 2023
 · 
1 min read
BioForest
Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy
November 17, 2023
 · 
4 min read
Biotech Bay
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
November 16, 2023
 · 
5 min read
Drug Development
Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma
November 15, 2023
 · 
8 min read
KAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY ABSTRACT HIGHLIGHTING PAXALISIB IN DIFFUSE MIDLINE GLIOMA PATIENTS AHEAD OF THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING
November 15, 2023
 · 
6 min read
Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
 · 
1 min read
Load More